Journal of Gastrointestinal & Digestive System
Open Access

Abstract

During the last years, Hepatocellular Carcinoma has become a public health issue in many countries. It is strongly related to cirrhosis that�s why surveillance each six months is recommended, than it allows diagnosis at an early stage, when effective therapies are possible. The best candidates for resection are patients with a solitary tumor and preserved liver function on the other hand liver transplantation is indicated in patients who are not good candidates for surgical resection, but are still meet in Milan or UCSF criteria for that matter. Image-guided ablation is the most frequently used therapeutic strategy, but its efficacy is limited by the size of the tumor and its localization. Trans arterial Chemoembolization has a survival benefit in patients with multifocal disease without vascular invasion or extrahepatic spread. Finally, sorafenib, lenvatinib, and regorafenib are the standard treatments in advanced hepatocellular carcinoma. This lecture gives a brief summary of the scientific evidence that supports the current recommendations for clinical practice.

Biography

E-mail: gusaguilarruiz@gmail.com